Skip to content
Screener

Goodwill at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$25.96B-1.8%
Stryker logo
StrykerSYK
$19.19B+0.5%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$3.6M0.0%
Globus Medical logo
Globus MedicalGMED
$1.44B+0.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$7.47M
MiMedx Group logo
MiMedx GroupMDXG
$19.44M0.0%

Segments

By segment

See full
Specialty Surgery$341.92M
Tissue Reconstruction$269.22M

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Line itemJune 30, 2026December 31, 2025
Property, plant and equipment, net446,202444,335
Right of use asset - operating leases137,085140,568
Intangible assets, net1,075,5421,134,663
Goodwill611,145615,157
Deferred tax assets, net70,44369,854
Other assets31,59137,880
Total assets$3,563,490$3,602,001
LIABILITIES AND STOCKHOLDERS’ EQUITY

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's goodwill?
Integra LifeSciences (IART) reported goodwill of $611.15M in Q2 2026.
How has Integra LifeSciences's goodwill changed year-over-year?
Integra LifeSciences's goodwill decreased by 0.9% year-over-year, from $616.43M to $611.15M.
What is the long-term trend for Integra LifeSciences's goodwill?
Over 5 years (2020 to 2025), Integra LifeSciences's goodwill has grown at a -8.0% compound annual growth rate (CAGR), from $932.37M to $615.16M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.

Ask your AI about Integra LifeSciences's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude